Physician Follow-up and Provider Continuity Are Associated With Long-term Medication Adherence
Authors:
- M. Alan BrookhartMBM. Alan Brookhart
- Amanda R. PatrickAPAmanda R. Patrick
- Sebastian SchneeweissSSSebastian Schneeweiss
- Jerry AvornJAJerry Avorn
- Colin DormuthCDColin Dormuth
- William ShrankWSWilliam Shrank
- Boris L. G. van WijkBWBoris L. G. van Wijk
- Suzanne M. CadaretteSuzanne M. Cadarette
- Claire F. CanningCCClaire F. Canning
- Daniel H. SolomonDSDaniel H. Solomon
Open Access
- 23 April 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 167 (8) , 847-852
Abstract
In patients with clinically evident coronary artery disease, statin (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor) therapy substantially reduces the risk of myocardial infarction (MI), stroke, and all-cause mortality.1-4 However, despite the safety and effectiveness of statins for secondary prevention, an important body of research has found that patient adherence to long-term statin therapy is poor, with many patients becoming nonadherent by 1 year.5-10Keywords
This publication has 1 reference indexed in Scilit: